Expertise in
3
conditions

Laurent Guilleminault

Toulouse, FR 
Expertise in
3
conditions
Toulouse, FR 

Overview

Laurent Guilleminault practices practicing medicine in Toulouse, France.

Mr. Guilleminault is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Chronic Cough, Asthma, Anaphylaxis, and Eosinophilic Asthma.

He is actively involved in clinical research, co-authoring 115 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Toulouse, France
Other Locations
Bobigny, France
Bordeaux, France
Tours, 37032, France
UMR 1188 Diabetes Atherothrombosis Therapies Reunion Island Indian Ocean, Reunion Island Indian Ocean Cyclotron Platform, Saint-etienne, France
Saint-pierre-les-bois, 97448, France
Francois, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Chronic Cough and Small Fiber Neuropathy
Chronic Cough and Small Fiber Neuropathy
Enrollment Status: Terminated
Publish Date: June 01, 2026
Intervention Type: Other
Study Phase: Not Applicable
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
Proteasis Evaluation in COPD
Proteasis Evaluation in COPD
Enrollment Status: Completed
Publish Date: August 26, 2021
View 2 Less Clinical Trials

114 Total Publications

French guidelines for severe asthma management
French guidelines for severe asthma management
Journal: Revue des maladies respiratoires
Published: July 01, 2026

Frequently Asked Questions about Laurent Guilleminault

Is Laurent Guilleminault a top-rated expert for Chronic Cough?

MediFind is an objective health platform that identifies experts based on real-world data. Laurent Guilleminault is classified as an Elite expert for Chronic Cough, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Laurent Guilleminault participate in research or clinical trials?

Yes. Laurent Guilleminault has published 114 articles and abstracts on conditions like Chronic Cough. You can view a list of Laurent Guilleminault's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guilleminault's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile